phrykt

Evolent Health, Inc. (EVH): who owns it and who trades it

As of Nov 16, 2026, EVH insiders reported 1 open-market sale worth $329K and 1 purchase worth $38.2K in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Daniel Joseph McCarthy (President), with $329K. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Evolent Health

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns EVH

199 funds and institutions reported EVH shares worth $620M at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 13.2%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.13.2%
Cadian Capital Management, LP9.6%
Morgan Stanley8.0%
UBS Group AG5.6%
Rubicon Founders LLC5.2%
Engaged Capital LLC4.9%
D. E. Shaw & Co., Inc.4.5%
Vanguard Capital Management LLC4.3%
Marshall Wace, LLP3.0%
Nuveen, LLC2.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.14.81M13.17%$80.3M+36%
Cadian Capital Management, LP10.81M9.61%$58.6MNo change
Morgan Stanley8.97M7.97%$48.6M-1%
UBS Group AG6.25M5.55%$33.8M-23%
Rubicon Founders LLC5.82M5.17%$31.5MNo change
Engaged Capital LLC5.56M4.95%$30.2MNo change
D. E. Shaw & Co., Inc.5.11M4.54%$27.7M-6%
Vanguard Capital Management LLC4.79M4.26%$26M-2%
Marshall Wace, LLP3.41M3.03%$18.5M+335%
Nuveen, LLC3.13M2.78%$17M+1081%
Geode Capital Management, LLC2.90M2.58%$15.7M+11%
Rock Springs Capital Management LP2.50M2.22%$13.6M-7%
State Street Corp2.46M2.19%$13.3M-7%
Charles Schwab Investment Management Inc2.13M1.90%$11.6M+9%
Sixth Street Partners Management Company, L.P.2.13M1.90%$11.6M–
Goldman Sachs Group Inc1.75M1.55%$9.5M-22%
Rock Point Advisors, LLC1.72M1.53%$9.3M-4%
Jacobs Levy Equity Management, Inc1.60M1.42%$8.7M+163%
Kennedy Capital Management LLC1.57M1.39%$8.5M-2%
Vanguard Portfolio Management LLC1.35M1.20%$7.3M+45%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, EVH insiders reported $38.2K of open-market purchases and $329K of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$38.2K
1 trades, 1 people
Sales, 12 months
$329K
1 trades, 1 people
Sales under a 10b5-1 plan
100%
Share of sale value
Latest trade
Aug 26, 2026
Filed Aug 28, 2026

Purchases and sales by month

$329K$329KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 26, 2026Daniel Joseph McCarthyPresidentSale plan65,892$5.00$329KForm 4
Nov 18, 2025Brendan B SpringstubbDirectorPurchase10,000$3.82$38.2KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Daniel Joseph McCarthyPRESIDENT–$329KAug 26, 2026
Brendan B SpringstubbDirector$38.2K–Nov 18, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

EVH short interest

Moderate short interest. 9.4% of EVH shares are sold short: about 1 share in 11. Over the last 12 reports the number of shares short went down 29%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 10.61M EVH shares were sold short, 9.4% of the shares outstanding, down 10.9% from the report before. At the average daily volume of 1.52M shares, buying them all back would take about 7.0 trading days (days to cover).

Shares short, % of all shares

9.38%May 15Oct 3014.8%

Days to cover

7.0May 15Oct 307.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202610.61M9.38%-11%1.52M7.0
Oct 15, 202611.90M10.53%-8%2.12M5.6
Sep 30, 202612.91M11.42%-8%2.36M5.5
Sep 15, 202614.07M12.44%-9%2.42M5.8
Aug 31, 202615.47M13.68%-2%2.65M5.8
Aug 14, 202615.77M13.95%-0%3.99M4.0
Jul 31, 202615.81M14.06%+8%4.36M3.6
Jul 15, 202614.69M13.06%-7%2.22M6.6
Jun 30, 202615.83M14.07%+9%2.68M5.9
Jun 15, 202614.58M12.97%-1%2.57M5.7
May 29, 202614.79M13.15%-1%2.33M6.4
May 15, 202614.94M13.29%-3%3.01M5.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Evolent Health company events

Evolent Health filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Aug 6, 2026ResultsReleased financial results. Filing
  3. Jun 4, 2026VoteReported shareholder vote results. Filing
  4. May 7, 2026ResultsReleased financial results. Filing
  5. Feb 24, 2026ResultsReleased financial results. Filing
  6. Dec 8, 2025AnnouncementEvolent Health LLC, a wholly owned subsidiary of Evolent Health, Inc., consummated the transactions contemplated by the previously announced Stock Purchase Agreement, dated September 23, 2025, by and between Evolent Health LLC and Privia Management Company, LLC. SIGNATURES Pursuant to the… Filing
  7. Dec 2, 2025LeadershipMs. Cheryl Scott retired from the Board of Directors of Evolent Health, Inc. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Evolent Health financials

Famous investors that hold EVH

3 of the 50 well-known investors we track reported holding EVH in their latest 13F filing. The largest position is Israel Englander's, worth $2.4M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026680,397$2.4M0.0%+124%
Ken Griffin · Citadel AdvisorsQ3 2026624,328$2.2M0.0%+28%
Steve Cohen · Point72 Asset ManagementQ3 2026566,905$2M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named EVH in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Cadian Capital Management, LP13G/A0.5%
Nov 16, 2026Cadian Capital Management, LP13G/A0.5%
Nov 13, 2026Rubicon Fund II LP13G/A4.4%
Nov 13, 2026Rubicon Fund II LP13G/A4.4%

Questions about Evolent Health, Inc. (EVH) stock

Who owns the most EVH stock?

The largest reported owner of Evolent Health, Inc. (EVH) is BlackRock, Inc., with 13.2% of the company. In total, 199 funds and institutions reported holding EVH at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are EVH insiders buying or selling?

In the last 12 months, EVH insiders reported 1 open-market purchase worth $38.2K and 1 sale worth $329K. The latest trade was on Aug 26, 2026. See every trade.

What is the short interest in EVH?

As of Oct 30, 2026, 10.61M EVH shares were sold short, 9.4% of the shares outstanding, down 10.9% from the report before. At the average daily volume of 1.52M shares, buying them all back would take about 7.0 trading days (days to cover). See the history.

Which famous investors hold EVH?

3 of the 50 well-known investors we track reported EVH in their latest 13F filing, including Israel Englander, Ken Griffin, Steve Cohen. The largest position is worth $2.4M. See all holders.

Executive pay

Evolent Health's chief executive was paid a total of $14.2M for the year ended Dec 31, 2025, up 28% from $11.1M the year before. In the last 12 months, Evolent Health's executives and directors bought $38.2K of stock on the open market and sold $329K.

Chief executive, total pay$14.2MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$2.6MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$5MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.